Veterans Admin. Med. Center1 and Depts of Medicine2, Microbiology3 and the Interdisciplinary Immunology Program4, University of Iowa, Iowa City, IA, USA
Author for correspondence: Larry S. Schlesinger. Tel: +1 319 356 1387. Fax: +1 319 356 7893. e-mail: larry-schlesinger{at}uiowa.edu
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Keywords: major histocompatibility complex Class II (MHC-II), tubercle bacillus, phagocytosis, granuloma, integrin
Abbreviations: AM, alveolar macrophage; EC3bi, C3bi-coated erythrocytes; HK, heat-killed; HRP, horseradish peroxidase; ICAM-1, counter receptor of LFA-1; LFA-1, lymphocyte function-associated antigen-1; MDM, monocyte-derived macrophage; MHC-II, major histocompatibility complex Class II; Mtb, Mycobacterium tuberculosis; TEM, transmission electron microscopy
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A key step in TB pathogenesis is the ability of the tubercle bacillus to enter and replicate within the macrophages of its human host (Schlesinger, 1996 ; Fenton, 1998
). During primary infection with the organism, aerosol-droplet nuclei containing small numbers of Mtb are deposited in the alveoli of the lung(s) and are subsequently phagocytosed by alveolar macrophages (AMs). Mtb enters the macrophages via receptor-mediated phagocytosis, a process involving complement receptors (CR1, CR3 and CR4), the mannose receptor and scavenger receptors (Schlesinger, 1993
; Zimmerli et al., 1996
; Hirsch et al., 1994
; Stokes et al., 1993
). After intracellular multiplication of Mtb, the bacilli spread to regional lymph nodes within the host. In the majority of cases, the host develops a protective response to Mtb infection that involves containment of the tubercle bacilli by the formation of granulomas that contain aggregated and fused (giant cells), apoptotic, infected macrophages (Saunders & Cooper, 2000
). Characterization of the bacterial and phagocyte molecular determinants that allow for bacterial dissemination during primary infection with Mtb and which mediate cellcell interactions is just beginning to occur (Pethe et al., 2001
).
Integrins are ß heterodimeric proteins that are found on most cell types; however, they are particularly abundant on leukocytes (Harris et al., 2000
; Plow et al., 2000
). Most integrins are constitutively inactive in resting cells, but are rapidly and reversibly activated in response to a variety of agonists, leading to highly regulated homotypic and heterotypic cell adhesion. Integrins are divided into families based upon the nature of the ß subunit, with the ß2 (leukocyte) integrin family found predominantly on leukocytes. Members of the ß2 integrin family share a common ß subunit (CD18) that associates with a unique
subunit to form the mature heterodimer.
Complement receptor CR3, the major integrin of phagocytic cells (mononuclear phagocytes and polymorphonucleocytes), is also expressed on natural-killer cells and a subset of lymphocytes. Its major functions include phagocytosis, homotypic aggregation and stable adhesion of leukocytes to endothelial cells, followed by migration into inflamed organs. These functions are mediated through the binding of CR3 to several physiological ligands, including C3bi, ICAM-1 (CD54) and fibrinogen (Ueda et al., 1994 ; Rieu et al., 1994
). Another complement receptor, CR4, shares the functions and ligands of CR3 (Blackford et al., 1996
; Ingalls & Golenbock, 1995
; Loike et al., 1991
) and has been shown to be a particularly important phagocytic receptor for Mtb on AMs (Hirsch et al., 1994
).
The ß2 integrin lymphocyte function-associated antigen-1 (LFA-1), although not a phagocytic receptor, plays a major role in cellular adhesion (Stewart et al., 1995 ). It is expressed on all leukocytes and mediates a broad range of functions, such as T-cell-mediated killing, T-helper-cell and B-cell responses, natural-killer-cell activity, monocyte-mediated antibody-dependent cytotoxicity and leukocyte adhesion to endothelial cells (Stewart et al., 1995
). LFA-1 mediates cell interactions through binding to one of its three counter receptors, ICAM-1, ICAM-2 or ICAM-3, which are members of the immunoglobulin superfamily.
Adhesion molecules, such as integrins, play a major role in communication with other cell types involved in the host cellular immune response. Modulation of expression and/or function of ß2 integrins on Mtb-infected cells may serve to regulate cell migration, homotypic cellular adhesion (i.e. granuloma formation) and antigen presentation by influencing cognate interactions with T-cells (Faull et al., 1994 ; Ochs et al., 1993
; Dubey & Croft, 1996
). Several other pathogens, including mycobacteria species, have evolved strategies to regulate host-cell-surface molecules (Keller et al., 1995
; Tsuyuguchi et al., 1990
; Kaye et al., 1986
; Mshana et al., 1988
; Mohagheghpour et al., 1997
). Studies of the effects of Mtb on host-cell-surface molecules are limited, but those that have been done include evidence for alterations in major histocompatibility complex Class II (MHC-II) molecules (Gercken et al., 1994
; Wadee et al., 1995
), ICAM-1 (Saha et al., 1994
; López Ramírez et al., 1994
) and co-stimulatory molecules (Saha et al., 1994
).
Using an in vitro culture model of human monocyte-derived macrophages (MDMs), we have observed a marked phenotypic change in these cells after their infection with live Mtb. Uninfected cultured macrophages appear as a monolayer of largely single cells; however, within 24 h of phagocytosis of Mtb by the MDMs (at a ratio of approximately 1 bacillus per macrophage), the macrophages begin to migrate and adhere to each other. As the Mtb replicate, the MDMs continue to aggregate; eventually the MDMs detach from the culture plate and are ultimately killed by the replicating bacteria. To begin to determine the mechanism behind these phenotypic changes in the MDMs, we investigated whether there is modulation of several major macrophage surface proteins during intracellular growth of Mtb.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Bacterial culture and infection of MDMs.
M. tuberculosis Erdman (ATCC 35801), H37Rv (ATCC 27294T) and H37Ra (ATCC 25177) were grown for 911 days on Middlebrook 7H11 agar. Immediately prior to the infection of the MDMs with Mtb, bacteria were scraped from the plates into a 2·0 ml polypropylene tube containing two 3 mm glass beads and 1 ml RPMI. The samples were pulse-vortexed six times (1 s per pulse) and the resulting suspensions were allowed to settle for 30 min as described previously (Schlesinger et al., 1990
). This bacterial suspension contained
1x108 (bacteria ml)-1, with zero to a few bacterial clumps observed by microscopy. The number of bacteria present in the suspension was confirmed by counting in a PetroffHauser chamber. Bacteria prepared in this fashion are
90% viable by c.f.u. assay (Ferguson et al., 2002
). Heat-killed (HK) bacteria were prepared as described above, except that the Mtb were heated for 1 h at 90 °C.
MDMs were incubated with Mtb for 2 h in the presence of 2·5% autologous serum; unattached bacilli were removed from the MDMs by washing. Infected macrophage monolayers and sham-infected (no Mtb) control MDMs were cultured for an additional 2472 h in RH plus 1% autologous serum. The m.o.i. (Mtb to MDMs) was <1:1 to 10:1, depending upon the experiment performed. Duplicate or triplicate wells were examined in each test group. Monolayers were examined daily using an inverted-phase microscope (model IMT; Olympus) at 100400xmagnification, and representative photomicrographs were taken. Viable MDMs were assessed by trypan-blue exclusion. In this model, at an m.o.i. of 1:1, the percentage of macrophages that contain intracellular Mtb is 32±3% (mean±SEM, n=9 experiments) at 2 h, 35±5% (n=9) at 24 h and 42±6% (n=5) at 72 h post-infection, as assessed by fluorescence microscopy (Schlesinger et al., 1990 ).
Transmission electron microscopy (TEM) quantification of surface expression of macrophage proteins in Mtb-infected cells.
At 6 min (synchronized phagocytosis; Schlesinger et al., 1990 ), 24 h or 72 h post-infection with Mtb, the macrophage monolayers were fixed with 2% paraformaldehyde, 10 mM sodium periodate, 75 mM L-lysine HCl and 37 mM phosphate buffer at 4 °C for 4 h. They were then washed three times with PBS (Dulbeccos phosphate-buffered saline without CaCl2 and MgCl2; Gibco BRL) plus 0·075% Tween 20. MDMs were blocked with 50% normal goat serum (NGS) in 0·15 M Tris-buffered saline (TBS) with 0·075% Tween 20 (TBST) at room temperature for 1 h with gentle shaking. Primary mAbs to the ß2 integrins (CD11a, CD11b and CD11c), ICAM-1, Fc
RII and HLA-DR (Beckman Coulter) were diluted 1:40 and incubated with the MDMs overnight at 4 °C in a solution of TBST with 50% NGS. An IgG-subtypic control was used to detect non-specific staining for each antibody.
After overnight incubation of the MDMs with the primary antibodies, the MDMs were washed and incubated in TBST plus 10% human serum and horseradish peroxidase (HRP)-conjugated goat-anti-mouse IgG secondary antibody for 3 h at room temperature with gentle shaking. The MDMs were then washed six times, and the HRP was developed with 0·05% 3,3'-diaminobenzidine (DAB) tetrahydrochloride and 0·003% H2O2 in TBS at room temperature for 30 min. Following development of the HRP, the MDMs were post-fixed with 2·5% glutaraldehyde in 0·1 M phosphate buffer for 1530 min, rinsed and then immersed in 1% OsO4 in 0·1 M phosphate buffer for 10 min. Thin-sections of the MDMs were then prepared for TEM.
The intensity of the cross-sectional surface staining of the MDMs was ranked on an ordinal scale from 0 to 3, counting a minimum of 40 macrophage cross-sections per test group examined. Level 0, designated A, indicates background staining; Level 1, designated B, indicates linear staining along the MDM plasma membrane separated by areas greater than the area of staining (i.e. <50% of the cells surface stained); Level 2, designated C, indicates linear staining along the MDM plasma membrane separated by areas less than the area of staining (i.e. between 50 and <100% of the cells surface stained); Level 3, designated D, indicates linear staining along the entire MDM plasma membrane without breaks (i.e. 100% of the cells surface stained).
Preparation of C3bi-coated erythrocytes (EC3bi) and zymosan particles, and their uptake by MDMs.
Sheep erythrocytes (SRBCs) (BioWhittaker) were washed and suspended in 10 mM HEPES/Hanks balanced salt solution buffer (pH 7·3) (HH buffer). SRBCs (6x108) in 10 ml HH buffer were incubated with 100 µl haemolysin at room temperature for 60 min. The SRBCs were then washed three times, suspended in 1·0 ml HH buffer and 100 µl C5-deficient human serum and incubated for 60 min at 37 °C, to opsonize the SRBCs with C3bi (EC3bi). EC3bi were washed three times before use.
Zymosan A (Zy; Sigma) was suspended in PBS at a concentration of 1 mg ml-1. The suspension was boiled for 30 min and washed twice at room temperature by centrifuging the suspension at 15800 g for 5 min between washes, to pellet the Zy.
EC3bi (m.o.i. of 33100 per MDM) or Zy (m.o.i. of 13:1) were incubated with MDM monolayers on glass coverslips for 30 min at 37 °C. To quantify the total number of cell-associated EC3bi per MDM, monolayers of MDMs were washed in PBS and fixed in 2·5% glutaraldehyde for 10 min; the red cells were then enumerated by phase-contrast microscopy. To distinguish internalized EC3bi from attached EC3bi, coverslips were briefly exposed to H2O prior to fixation of the MDMs to hypotonically lyse the attached EC3bi (Schlesinger & Horwitz, 1991 ). The number of attached EC3bi were calculated by subtracting the number of internalized EC3bi from the total number of cell-associated EC3bi. The uptake of Zy by the MDMs was enumerated by phase-contrast microscopy.
Data reported here represent particles associated with 50300 consecutive MDMs on duplicate or triplicate coverslips per test group. Statistical significance of the data was calculated using the paired t-test. The level of phagocytosis by the MDMs varied between individual donors; therefore, certain results are reported as the percentage of particles associated in each treatment group (i.e. live or HK Mtb) compared to the number of particles associated with that donors sham-infected MDMs (normalized to an internal control for each experiment).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Macrophage surface expression of LFA-1 and ICAM-1 was increased following infection of monolayers with Mtb for 72 h
Because of the marked increase in cellular aggregation seen to accompany infection of the macrophages with Mtb for 72 h, we examined the level of macrophage surface expression of the ß2 integrin LFA-1 and its counter receptor ICAM-1, two proteins known to play a major role in cellcell adhesion. Quantitative TEM was used to measure the surface expression of these two proteins on MDM cross-sections of uninfected and Mtb-infected cells (Erdman and H37Ra strains). An ordinal scale was developed based on the degree of surface staining of the macrophage proteins as revealed by developing the HRP substrate (Fig. 2AE). The amount of staining on the surface of
40 MDM cross-sections per experimental group was calculated using the ordinal scale designated as AD, where A indicated no antibody staining and D indicated 100% surface staining (see Methods).
|
|
To determine the specificity of the complement-receptor response upon infection of the MDMs with Mtb, we also analysed the surface expression of FcRII. Similar to the results obtained for CR3 and CR4 expression, the expression of Fc
RII was decreased on monolayers infected with Mtb for 72 h (Fig. 3
). Thus, in contrast to the macrophage surface proteins LFA-1 and ICAM-1 which play major roles in cellcell adhesion and whose expression is increased following infection of the monolayer with Mtb, the expression of surface proteins that mediate phagocytosis is decreased.
Finally, we assessed whether the expression of the MHC-II molecule HLA-DR, which is involved in antigen presentation, is altered following infection of the macrophages with Mtb. Similar to the results obtained for LFA-1 and ICAM-1 expression, the surface expression of MHC-II was increased (Fig. 3). Taken together, our data indicate that macrophages infected with Mtb display marked alterations in a variety of surface proteins that are known to play an important role in modulating the host immune response during infection with this bacterium.
Kinetics of changes in macrophage protein surface expression following infection of monolayers with Mtb
The studies described above focused on the changes in macrophage protein expression 72 h post-infection with Mtb, and were based on the marked degree of cellular aggregation observed in light microscopy studies (Fig. 1). However, changes in the macrophage monolayer began to occur as early as 24 h post-infection with Mtb. Also, it was possible that the regulation of specific macrophage surface proteins could begin during the process of Mtb phagocytosis. To examine the kinetics of the regulation of macrophage surface proteins following Mtb infection, we performed quantitative TEM analyses on a subset of proteins at 6 min post-infection (synchronized phagocytosis) and at 24 h post-infection. As shown in Fig. 3
, only small changes in LFA-1 expression were seen at 6 min post-infection; however, there was a marked increase in the expression of this protein by 24 h post-infection. Fc
RII expression was decreased at 24 h post-infection. The most striking changes in macrophage protein expression were seen for CR3 and MHC-II. As early as 6 min post-infection, there was a marked reduction in CR3 expression by the macrophages when infected with either Erdman or H37Ra; this reduction in expression persisted at 24 h post-infection. MHC-II expression showed a biphasic response: its expression was decreased at 6 min post-infection, returned towards the level of uninfected cells at 24 h post-infection and then showed increased expression at 72 h post-infection.
Macrophage monolayers infected with live Mtb were reduced in their phagocytic abilities via complement receptors and the mannose receptor
TEM results revealed that macrophage surface expression of the phagocytic receptors CR3 and CR4 decreased following infection of the monolayer with Mtb. To determine if the decreased expression of these receptors had a functional correlate (i.e. decreased phagocytosis), we examined the effect of Mtb infection on macrophage complement-receptor activity, by measuring the association of EC3bi with Mtb-infected monolayers at 72 h post-infection. EC3bi, which bind to CR3 and CR4, were incubated with monolayers for 30 min at 37 °C and the mean number of EC3bi associated with individual macrophages was enumerated by phase-contrast microscopy. For these experiments, we elected to compare results from monolayers infected with the virulent strains of Mtb (Erdman and H37Rv), and the importance of bacterial viability by comparing the effects of live and HK Mtb on the monolayers. The results showed that macrophage monolayers infected with live Mtb Erdman or Mtb H37Rv, but not HK Mtb, demonstrated a reduced total cell association of EC3bi via CR3 and CR4 (P=0·003) (Fig. 4a and Table 1
). Concomitant with the observed reduction in the mean number of EC3bi particles per infected macrophage, there was a significant reduction (P=0·006) in the percentage of EC3bi-associated macrophages compared to the uninfected control or HK Mtb groups (Fig. 4b
). In a similar fashion, infection of the macrophages with live H37Ra, but not HK H37Ra, decreased EC3bi association with the macrophages (live bacteria 60±13%, n=4, and HK bacteria 123±4%, n=3; results are expressed as a percentage of the control value).
|
|
Another macrophage receptor for Mtb phagocytosis is the mannose receptor. To determine whether the functional activity of this receptor was altered in Mtb-infected monolayers, we assessed the association of unopsonized zymosan, a particle that is phagocytosed primarily by the mannose receptor on human macrophages (Speert & Silverstein, 1985 ), with the macrophages. Similar to the results obtained for EC3bi association, there was a reduction in the mean number of zymosan particles per macrophage in Mtb-infected monolayers compared to uninfected (control) monolayers (51±8% and 55±17% of control, respectively, for live Erdman-infected and live H37Rv-infected cells, n=2). Thus, together with the TEM data, our results indicate that macrophage monolayers infected with live Mtb have reductions in expression of the major classes of receptors for phagocytosis on these cells.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
During primary infection of the host with Mtb, inhaled Mtb encounters AMs. AMs are highly effective at clearing foreign particulate matter from the lungs, including microbes deposited on the epithelial surface of the lungs, and at the same time serve to downregulate the activation of the immune system present in lung tissue and in draining lymph nodes (Thepen et al., 1994 ; Herscowitz, 1985
; Schauble et al., 1993
). The alveoli also contain type I and type II alveolar epithelial cells which express ICAM-1 (the counter receptor for ß2 integrins) and, thus, may mediate adhesion and migration of professional phagocytes within the lungs (Simon & Paine, 1995
).
After the intracellular multiplication of Mtb within AMs, there is spread of the bacilli to regional lymph nodes. The mechanism by which the bacilli traverse the alveoli remains poorly understood. One mechanism may involve the migration of AMs containing Mtb across the alveoli to the nodes of the lung. Evidence for this comes, in part, from studies in dogs, in which red and green fluorescently labelled microsphaeres instilled separately into the trachea of these animals were found together within single macrophages in the draining lymph nodes, and from a more-recent study that followed the movement of inflammatory macrophages in a murine model (Harmsen et al., 1985 ; Bellingan et al., 1996
). Our data support the idea that increases in the expression of LFA-1, ICAM-1 and potentially other integrins by Mtb-infected macrophages may enhance the cellular migration of these macrophages in the lungs. Alternatively, it has also been proposed that mycobacteria may directly penetrate damaged alveolar epithelial tissue, may move intercellularly to gain access to lymph nodes and the circulatory system or may transit to the lymph nodes by dendritic cells (Lambrecht et al., 2001
; Demangel et al., 1999
; McDonough & Kress, 1995
; Zhang et al., 1997
).
Human AMs and MDMs express CR3, CR4 and the mannose receptor, receptors known to mediate the phagocytosis of opsonic and non-opsonic Mtb and other mycobacteria in the naïve host (Schlesinger, 1996 ). Along with the production of specific antibodies by the host during infection with Mtb, Fc
Rs may also play an important role in mycobacterial entry and the host response (Teitelbaum et al., 1998
). Our data provide evidence that there is downregulation of the expression of these phagocytic receptors during the intracellular growth of Mtb in macrophages. Whether these changes in receptor expression are to the benefit of the microbe or the host is not known. We speculate that decreases in the expression of these receptors act to reduce the phagocytic capacity of an already-infected cell, potentially allowing for maintenance of the intracellular niche of Mtb for a longer period of time. With further intracellular growth of the bacterium, Mtb-infected macrophages undergo apoptosis and, ultimately, cell lysis (Fratazzi et al., 1999
; Placido et al., 1997
; Keane et al., 1997
). Consistent with our results, treatment of human monocytes with Mycobacterium avium complex (MAC) or MAC-derived lipid resulted in significant decreases in the expression of CR3 (Tsuyuguchi et al., 1990
; Pourshafie et al., 1993
). Furthermore, in earlier studies, Mtb-infected mononuclear phagocytes and Mycobacterium bovis BCG-infected mouse peritoneal macrophages were found to have altered phagocytic receptor functions (Mariano et al., 1977
; Ezekowitz et al., 1981
).
A significant component of the granulomas found in hosts infected with Mtb is composed of aggregated and fused macrophages. The cellular adhesion that we observed with MDM monolayers infected with live Mtb could represent a stage in the formation of granulomas. The mechanism(s) underlying the changes in macrophage phenotype and integrin expression upon infection with Mtb is the focus of current studies. These studies include evaluating whether the changes in cellular adhesion are due to autocrine and/or paracrine effects our data are suggestive of a paracrine effect. We observed global changes in the macrophage monolayer despite only a proportion of the cells containing Mtb, as assessed by fluorescence microscopy. Also, as assessed by TEM, there was no observed difference in the levels of surface-protein-staining on macrophage cross-sections that contained a bacterium when compared with those that did not. However, TEM is limited by it being a cross-sectional analysis of cells.
Cognate interactions between antigen-presenting cells and T-cells involve both T-cell-receptorMHCantigen binding and binding between several accessory molecules, such as LFA-1 and ICAM-1, as well as co-stimulatory molecules. The upregulation of the expression of LFA-1, ICAM-1 and HLA-DR observed in our study suggests enhanced T-cell interactions; however, other accessory molecules that have not yet been studied may be downregulated, so it is difficult to predict the ultimate result of this upregulation. Our results with regard to the regulation of MHC-II expression on Mtb-infected human macrophages deserve comment. We observed an early decrease in MHC-II expression followed by an increase in MHC-II expression at 72 h post-infection with Mtb. Several studies support the idea that mycobacteria-infected cells have a diminished capacity for MHC-II-restricted antigen presentation (Gercken et al., 1994 ; Pancholi et al., 1993
; Hmama et al., 1998
). However, the degree to which this relates to MHC-II expression remains uncertain. Different studies have shown decreased expression of MHC-II, no change in its expression or an increase in its expression (Noss et al., 2000
; Pancholi et al., 1993
; Gercken et al., 1994
; Ezekowitz et al., 1981
; VanHeyningen et al., 1997
; Tsuyuguchi et al., 1990
).
The requirement for viable bacteria to infect macrophages to generate the MHC-II response varies in different studies (Hmama et al., 1998 ; Gercken et al., 1994
; Noss et al., 2000
). Mtb cell-wall components alone can effect the expression of MHC-II (Wadee et al., 1995
; Noss et al., 2001
). In some cases, IFN-
-induced MHC-II expression is decreased rather than the constitutive expression of MHC-II after infection with Mtb (Wojciechowski et al., 1999
; Hmama et al., 1998
) as shown in this study. Changes in the expression of MHC-II also relate to the initial m.o.i. used (Gercken et al., 1994
; Hmama et al., 1998
). Whereas other studies have required a high m.o.i. to observe an effect on MHC-II expression, our studies revealed a marked effect on the expression of MHC-II at a low m.o.i. (1:1). The type and differentiation state of the macrophage cells used, as well as their time in culture, may be important factors for determination of the MHC-II response (Pancholi et al., 1993
; Hmama et al., 1998
; Hamerman & Aderem, 2001
). Studies have been conducted with murine macrophages, the myeloid-cell-line THP-1 and human monocytes (Pancholi et al., 1993
; Gercken et al., 1994
; Noss et al., 2000
). Monocytes in short-term culture may be particularly sensitive to MHC-II regulation (Hmama et al., 1998
; Gercken et al., 1994
). Our studies were conducted with MDMs. The biphasic response we observed in this study most closely resembles that seen with M. bovis BCG and mouse peritoneal macrophages (Hamerman & Aderem, 2001
; Ezekowitz et al., 1981
). Thus, the mechanism(s) underlying the regulation of MHC-II expression/function is complex. The kinetic analysis done in our study indicates that changes in protein expression in Mtb-infected human MDMs vary markedly with time in culture. Early changes in protein expression may relate, in part, to protein sorting during phagocytosis and later changes may depend more on intracellular growth. These possibilities are being explored.
Apart from MHC-II molecules, Mtb-containing macrophages from a susceptible mouse strain manifest reduced expression of the co-stimulatory molecule B7 (CD80) and increased expression of ICAM-1, resulting in T-cell unresponsiveness that appeared to be linked to prostaglandin synthesis (Saha et al., 1994 ). Incubation with Mtb or lipoarabinomannan enhanced the expression of ICAM-1 by THP-1 cells, in part by secretion of TNF-
(López Ramírez et al., 1994
)
The alterations in ß2 integrin protein expression (and in expression of other surface molecules) that we have observed in the MDMs provide evidence that the phenotype and function of Mtb-infected human macrophages will be markedly altered compared to uninfected macrophages. Several published studies on mycobacterial-infected cells, including those using arrays, support this view (Stenger et al., 1998 ; Ehrt et al., 2001
; Wang et al., 2000
; Ragno et al., 1997
). Given that the expression and/or function of CR3, CR4, FC
Rs and the mannose receptor are decreased and the expression and/or function of LFA-1, ICAM-1 and HLA-DR are increased, we hypothesize that there is a shift from a cell potent in phagocytosis to a cell with enhanced adhesive capabilities that influence cellcell interactions (e.g. attachment to and migration across epithelial tissue and cognate interactions with T-cells), in a fashion resembling the maturation of dendritic cells. In support of this hypothesis, a functional transitional state of macrophages was recently found in murine peritoneal macrophages infected with M. bovis BCG (Hamerman & Aderem, 2001
).
![]() |
ACKNOWLEDGEMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Blackford, J., Reid, H. W., Pappin, D. J. C., Bowers, F. S. & Wilkinson, J. M. (1996). A monoclonal antibody, 3/22, to rabbit CD11c which induces homotypic T cell aggregation: evidence that ICAM-1 is a ligand for CD11c/CD18. Eur J Immunol 26, 525-531.[Medline]
Demangel, C., Bean, A. G., Martin, E., Feng, C. G., Kamath, A. T. & Britton, W. J. (1999). Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guerin-infected dendritic cells. Eur J Immunol 29, 1972-1979.[Medline]
Dubey, C. & Croft, M. (1996). Accessory molecule regulation of naive CD4 T cell activation. Immunol Res 15, 114-125.[Medline]
Ehrt, S., Schnappinger, D., Bekiranov, S., Drenkow, J., Shi, S., Gingeras, T. R., Gaasterland, T., Schoolnik, G. & Nathan, C. (2001). Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 194, 1123-1140.
Ezekowitz, R. A. B., Austyn, J., Stahl, P. D. & Gordon, S. (1981). Surface properties of bacillus CalmetteGuerin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia. J Exp Med 154, 60-76.[Abstract]
Faull, R. J., Kovach, N. L., Harlan, J. M. & Ginsberg, M. H. (1994). Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: two mechanisms with divergent biological consequences. J Exp Med 179, 1307-1316.[Abstract]
Fenton, M. J. (1998). Macrophages and tuberculosis. Curr Opin Hematol 5, 72-78.[Medline]
Ferguson, J. S., Voelker, D. R., Ufnar, J. A. & Schlesinger, L. S. (2002). Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J Immunol 168, 1309-1314.
Fratazzi, C., Arbeit, R. D., Carini, C., Balcewicz-Sablinska, M. K., Keane, J., Kornfeld, H. & Remold, H. C. (1999). Macrophage apoptosis in mycobacterial infections. J Leukoc Biol 66, 763-764.[Abstract]
Gercken, J., Pryjma, J., Ernst, M. & Flad, H.-D. (1994). Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes. Infect Immun 62, 3472-3478.[Abstract]
Hamerman, J. A. & Aderem, A. (2001). Functional transitions in macrophages during in vivo infection with Mycobacterium bovis bacillus CalmetteGuérin. J Immunol 167, 2227-2233.
Harmsen, A. G., Muggenburg, B. A., Snipes, M. B. & Bice, D. E. (1985). The role of macrophages in particle translocation from lungs to lymph nodes. Science 230, 1277-1280.[Medline]
Harris, E. S., McIntyre, T. M., Prescott, S. M. & Zimmerman, G. A. (2000). The leukocyte integrins. J Biol Chem 275, 23409-23412.
Herscowitz, H. B. (1985). In defense of the lung: paradoxical role of the pulmonary alveolar macrophage. Ann Allergy 55, 634-650.[Medline]
Hirsch, C. S., Ellner, J. J., Russell, D. G. & Rich, E. A. (1994). Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 152, 743-753.
Hmama, Z., Gabathuler, R., Jefferies, W. A., de Jong, G. & Reiner, N. E. (1998). Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J Immunol 161, 4882-4893.
Ingalls, R. R. & Golenbock, D. T. (1995). CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med 181, 1473-1479.[Abstract]
Kaye, P. M., Sims, M. & Feldmann, M. (1986). Regulation of macrophage accessory cell activity by mycobacteria. II. In vitro inhibition of Ia expression by Mycobacterium microti. Clin Exp Immunol 64, 28-34.[Medline]
Keane, J., Balcewicz-Sablinska, M. K., Remold, H. G., Chupp, G. L., Meek, B. B., Fenton, M. J. & Kornfeld, H. (1997). Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 65, 298-304.[Abstract]
Keller, R., Keist, R. & Joller, P. (1995). Macrophage response to microbial pathogens: modulation of the expression of adhesion, CD14, and MHC class II molecules by viruses, bacteria, protozoa and fungi. Scand J Immunol 42, 337-344.[Medline]
Lambrecht, B. N., Prins, J.-B. & Hoogsteden, H. C. (2001). Lung dendritic cells and host immunity to infection. Eur Respir J 18, 692-704.
Loike, J. D., Sodeik, B., Cao, L., Leucona, S., Weitz, J. I., Detmers, P. A., Wright, S. D. & Silverstein, S. C. (1991). CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A chain of fibrinogen. Proc Natl Acad Sci USA 88, 1044-1048.[Abstract]
López Ramírez, G. M., Rom, W. N., Ciotoli, C., Talbot, A., Martiniuk, F., Cronstein, B. & Reibman, J. (1994). Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells. Infect Immun 62, 2515-2520.[Abstract]
Mariano, M., Nikitin, T. & Malucelli, B. E. (1977). Phagocytic potential of macrophages from within delayed hypersensitivity-mediated granulomata. J Pathol 123, 27-33.[Medline]
McDonough, K. A. & Kress, Y. (1995). Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect Immun 63, 4802-4811.[Abstract]
Mohagheghpour, N., Gammon, D., van Vollenhoven, A., Hornig, Y., Bermudez, L. E. & Young, L. S. (1997). Mycobacterium avium reduces expression of costimulatory/adhesion molecules by human monocytes. Cell Immunol 176, 82-91.[Medline]
Mshana, R. N., Hastings, R. C. & Krahenbuhl, J. L. (1988). Infection with live mycobacteria inhibits in vitro detection of Ia antigen on macrophages. Immunobiology 177, 40-54.[Medline]
Noss, E. H., Harding, C. V. & Boom, W. H. (2000). Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immunol 201, 63-74.[Medline]
Noss, E. H., Pai, R. K., Sellati, T. J., Radolf, J. D., Belisle, J., Golenbock, D. T., Boom, W. H. & Harding, C. V. (2001). Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 167, 910-918.
Ochs, H. D., Nonoyama, S., Zhu, Q., Farrington, M. & Wedgwood, R. J. (1993). Regulation of antibody responses: the role of complement and adhesion molecules. Clin Immunol Immunopathol 67, S33-40.[Medline]
Olakanmi, O., Britigan, B. E. & Schlesinger, L. S. (2000). Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect Immun 68, 5619-5627.
Pancholi, P., Mirza, A., Bhardwaj, N. & Steinman, R. M. (1993). Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science 260, 984-986.[Medline]
Pethe, K., Alonso, S., Miet, F., Delogu, G., Brennan, M. J., Locht, C. & Menozzi, F. D. (2001). The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412, 190-194.[Medline]
Placido, R., Mancino, G., Amendola, A. & 7 other authors (1997). Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J Pathol 181, 3138.[Medline]
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J. & Smith, J. W. (2000). Ligand binding to integrins. J Biol Chem 275, 21785-21788.
Pourshafie, M., Ayub, Q. & Barrow, W. W. (1993). Comparative effects of Mycobacterium avium glycopeptidolipid and lipopeptide fragment on the function and ultrastructure of mononuclear cells. Clin Exp Immunol 93, 72-79.[Medline]
Ragno, S., Estrada, I., Butler, R. & Colston, M. J. (1997). Regulation of macrophage gene expression following invasion by Mycobacterium tuberculosis. Immunol Lett 57, 143-146.[Medline]
Raviglione, M. C., Snider, D. E., Jr & Kochi, A. (1995). Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA (J Am Chem Soc) 273, 220226.[Abstract]
Rieu, P., Ueda, T., Haruta, I., Sharma, C. P. & Arnaout, M. A. (1994). The A-domain of ß2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF. J Cell Biol 127, 2081-2091.[Abstract]
Saha, B., Das, G., Vohra, H., Ganguly, N. K. & Mishra, G. C. (1994). MacrophageT cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur J Immunol 24, 2618-2624.[Medline]
Saunders, B. M. & Cooper, A. M. (2000). Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 78, 334-341.[Medline]
Schauble, T. L., Boom, W. H., Finegan, C. K. & Rich, E. A. (1993). Characterization of suppressor function of human alveolar macrophages for T lymphocyte responses to phytohemagglutinin: cellular selectivity, reversibility, and early events in T cell activation. Am J Respir Cell Mol Biol 8, 89-97.[Medline]
Schlesinger, L. S. (1993). Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 150, 2920-2930.
Schlesinger, L. S. (1996). Entry of Mycobacterium tuberculosis into mononuclear phagocytes. Curr Top Microbiol Immunol 215, 71-96.[Medline]
Schlesinger, L. S. & Horwitz, M. A. (1991). Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and interferon-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. J Immunol 147, 1983-1994.
Schlesinger, L. S., Bellinger-Kawahara, C. G., Payne, N. R. & Horwitz, M. A. (1990). Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 144, 2771-2780.
Simon, R. H. & Paine, R.3rd (1995). Participation of pulmonary alveolar epithelial cells in lung inflammation. J Lab Clin Med 126, 108-118.[Medline]
Snider, D. E.Jr & La Montagne, J. R. (1994). The neglected global tuberculosis problem: a report of the 1992 World Congress on Tuberculosis. J Infect Dis 169, 1189-1196.[Medline]
Speert, D. P. & Silverstein, S. C. (1985). Phagocytosis of unopsonized zymosan by human monocyte-derived macrophages: maturation and inhibition by mannan. J Leukoc Biol 38, 655-658.[Abstract]
Stenger, S., Niazi, K. R. & Modlin, R. L. (1998). Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol 161, 3582-3588.
Stewart, M., Thiel, M. & Hogg, N. (1995). Leukocyte integrins. Curr Opin Cell Biol 7, 690-696.[Medline]
Stokes, R. W., Haidl, I. D., Jefferies, W. A. & Speert, D. P. (1993). Mycobacteriamacrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J Immunol 151, 7067-7076.
Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J. B., Unanue, E., Casadevall, A. & Bloom, B. R. (1998). A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA 95, 15688-15693.
Thepen, T., Kraal, G. & Holt, P. G. (1994). The role of alveolar macrophages in regulation of lung inflammation. Ann N Y Acad Sci 725, 200-206.[Medline]
Tsuyuguchi, I., Kawasumi, H., Takashima, T., Tsuyuguchi, T. & Kishimoto, S. (1990). Mycobacterium aviumMycobacterium intracellulare complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity. Infect Immun 58, 1369-1378.[Medline]
Ueda, T., Rieu, P., Brayer, J. & Arnaout, M. A. (1994). Identification of the complement iC3b binding site in the ß2 integrin CR3 (CD11b/CD18). Proc Natl Acad Sci USA 91, 10680-10684.
VanHeyningen, T. K., Collins, H. L. & Russell, D. G. (1997). IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J Immunol 158, 330-337.[Abstract]
Wadee, A. A., Kuschke, R. H. & Dooms, T. G. (1995). The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin Exp Immunol 100, 434-439.[Medline]
Wang, T., Lafuse, W. P. & Zwilling, B. S. (2000). Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J Immunol 165, 6308-6313.
Wojciechowski, W., DeSanctis, J., Skamene, E. & Radzioch, D. (1999). Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus CalmetteGuerin involves class II transactivator and depends on the Nramp1 gene. J Immunol 163, 2688-2696.
Zhang, M., Kim, K. J., Iyer, D., Lin, Y., Belisle, J., McEnery, K., Crandall, E. D. & Barnes, P. F. (1997). Effects of Mycobacterium tuberculosis on the bioelectric properties of the alveolar epithelium. Infect Immun 65, 692-698.[Abstract]
Zimmerli, S., Edwards, S. & Ernst, J. D. (1996). Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Respir Cell Mol Biol 15, 760-770.[Abstract]
Received 24 May 2002;
revised 1 August 2002;
accepted 2 August 2002.